You are here

  • Home
  • Archive
  • Volume 59, Issue 3
  • Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex

Article Text

Article menu

This article has a correction. Please see:

Download PDFPDF
Extended report
Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex
  1. P Demettera,
  2. D Baetenb,
  3. F De Keyserb,
  4. M De Vosc,
  5. N Van Dammeb,
  6. G Verbruggenb,
  7. S Vermeulend,
  8. M Mareeld,
  9. D Elewautb,
  10. H Mielantsb,
  11. E M Veysb,
  12. C A Cuveliera
  1. aDepartment of Pathology, University Hospital, University of Gent, University Hospital, 6 Blok A, De Pintelaan 185, 9000 Gent, Belgium, bDepartment of Rheumatology, University Hospital, University of Gent, cDepartment of Gastroenterology, University Hospital, University of Gent, dDepartment of Experimental Cancerology, University Hospital, University of Gent
  1. Dr Demetter

Abstract

OBJECTIVE Previously an upregulation of E-cadherin and its associated molecules α-catenin, β-catenin and plakoglobin has been demonstrated in clinically overt inflammatory bowel disease (IBD). The aim of this study was to investigate the expression of the E-cadherin/catenin complex in subclinically inflamed bowel mucosa from spondyloarthropathy (SpA) patients.

METHODS Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, β-catenin and plakoglobin and a polyclonal antibody against α-catenin. E-cadherin mRNA was detected using a riboprobe. Inflammation was histologically classified into acute, chronic active and chronic quiescent forms.

RESULTS In acute and chronic active bowel inflammation of SpA patients, upregulation of the E-cadherin/catenin glycoprotein complex could be observed. Chronic lesions in a quiescent state did not show such an upregulation. Furthermore, chronic inflammation was associated with an increase in E-cadherin mRNA.

CONCLUSIONS As some of the SpA patients with subclinical gut inflammation develop IBD, upregulation of the E-cadherin/catenin complex in inflamed bowel mucosa from SpA patients may point to early cellular changes in the development of IBD. However, at present it cannot be excluded that increased E-cadherin/catenin complex expression is a bystander phenomenon of active inflammation.

  • spondyloarthropathy
  • inflammatory bowel disease
  • E-cadherin
  • catenins

https://doi.org/10.1136/ard.59.3.211

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Linked Articles

    • Correction
      Correction for vol. 59, p. 211
      BMJ Publishing Group Ltd and European League Against Rheumatism
      Annals of the Rheumatic Diseases 2000; 59 400-400 Published Online First: 01 May 2000. doi: 10.1136/ard.60..ii53